-
Francesco Aprile is a distinguished pharmaceutical scientist and molecular engineer, widely recognized for his groundbreaking contributions to targeted drug discovery and chemical biology. He holds a Ph.D. in Chemical Biology from the University of Cambridge, where his doctoral research on protein misfolding dynamics laid new foundations for understanding neurodegenerative diseases. Prior to this, he graduated summa cum laude with an M.S. in Pharmaceutical Chemistry from the University of Bologna, specializing in computer-aided drug design. With over fifteen years of experience bridging academia and the pharmaceutical industry, Dr. Aprile has established a formidable career. He served as a Principal Investigator at the Institute for Advanced Chemical Technologies, leading a multi-disciplinary team that successfully brought three novel small-molecule oncology candidates into Phase I clinical trials. Later, he transitioned to the global biotechnology sector as the Senior Director of Medicinal Chemistry at Aethel Therapeutics, where he spearheaded the development of next-generation covalent inhibitors and targeted protein degradation platforms. Dr. Aprile has authored more than eighty peer-reviewed papers in high-impact journals and holds twelve patents in molecular design. As the Editor-in-Chief of the Handbook of Medicinal Chemistry: Principles and Practice, he synthesizes his extensive industry insights and academic rigor into a definitive, masterfully curated guide. Matthew Fuchter is a world-renowned medicinal chemist and molecular architect who serves as the Editor-in-Chief for the definitive reference text, Handbook of Medicinal Chemistry: Principles and Practice. His academic qualificatios include, Ph.D. in Organic Chemistry - Imperial College London; B.Sc. in Chemistry (First Class Honours) - University of Bristol; Postdoctoral Research Fellowship - The Albert Einstein College of Medicine, New York Dr. Fuchter currently holds the position of Professor of Medicinal Chemistry at a prestigious global research institution. Over his 20-year career, his work has bridged the gap between fundamental organic synthesis and clinical drug discovery. Before taking the helm of the Handbook of Medicinal Chemistry, Dr. Fuchter co-founded two biotechnology spin-out companies focused on epigenetic modifiers and light-activated therapies. He has published over 150 peer-reviewed papers in high-impact journals and holds dozens of patents for novel therapeutic agents.
-
$280.00